Pages

Wednesday, August 27, 2014

Bellicum Pharmaceuticals nabs $55 mln Series C

Bellicum Pharmaceuticals, Inc., a biotechnology company focused on developing safer and more effective cellular immunotherapies, today announced the successful completion of a $55M Series C financing.

http://ift.tt/1mSp2dF

No comments:

Post a Comment